FOA
VRTX icon

Five Oceans Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Five Oceans Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
506
-2
-0.4% -$886 0.08% 169
2026
Q1 		$227K Buy
508
+1
+0.2% +$466 0.08% 168
2025
Q4 		$230K Buy
+507
New +$219K 0.08% 161
2025
Q3 		– Sell
-523
Closed -$233K – 196
2025
Q2 		$233K Sell
523
-1
-0.2% -$461 0.1% 158
2025
Q1 		$254K Buy
524
+3
+0.6% +$1.4K 0.12% 127
2024
Q4 		$210K Buy
521
+3
+0.6% +$1.39K 0.1% 162
2024
Q3 		$241K Hold
518
– – 0.12% 156
2024
Q2 		$243K Sell
518
-47
-8% -$20.4K 0.13% 135
2024
Q1 		$236K Hold
565
– – 0.12% 158
2023
Q4 		$230K Buy
+565
New +$209K 0.13% 143

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Five Oceans Advisors's VRTX Position: Q2 2026 in Review

Five Oceans Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 0.39% in Q2 2026, selling an estimated $886 and leaving 506 shares worth $251K. The position accounts for 0.08% of the portfolio, ranked #169.

Five Oceans Advisors first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $254K in Q1 2025. 293 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Five Oceans Advisors held 506 shares of Vertex Pharmaceuticals worth $251K as of Q2 2026.
  • Five Oceans Advisors sold 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
  • Vertex Pharmaceuticals made up 0.08% of Five Oceans Advisors's portfolio in Q2 2026, its #169 holding.
  • Five Oceans Advisors first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Five Oceans Advisors's Vertex Pharmaceuticals position peaked at $254K in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.